Yahoo India Web Search

Sign In

  1. Ad

    related to: genova biopharma
  2. abzena.com/cdmo+cro

    Contract Biopharma Services - Abzena Biologics+Bioconjugates

    Using our rich history in R&D we design and develop methods to ensure success. Fast. We are Abzena. The leading Bioconjugates & Biologics CDMO+CRO. Move your medicine forward.

    Service catalog: ADC Developability, ADC Design, ADC Manufacturing, Bioconjugation

    • About Abzena

      We are a leading complex biologics

      and bioconjugates CDMO + CRO.

    • Abzena Locations

      We operate from state-of-the-art

      facilities in the US and the UK.

Search results

  1. tracxn.com › d › companiesGENOVA - 2188 Competitors and alternatives in May 2024 - Tracxn

    May 25, 2024 · MedWatch - Lake Mary based, 1988 founded, Funding Raised company. Yamato Sangyo - Nara based, 1963 founded, Acquired company. Aaryan Technologies - Rajkot based, 2002 founded, Unfunded company. GENOVA has 2188 active competitors. Competitors include Univercells, Sutro Biopharma.

  2. www.dnaindia.com › health › report-know-howKnow how indigenous mRNA GEMCOVAC-19 vaccine can prove to be ...

    Jul 1, 2022 · DNA Web Team. The Drug Controller General of India (DCGI) has approved the first indigenous mRNA Covid vaccine developed in India for emergency use. Pune-based company Genova Biopharma has made this vaccine. It will be given to people of 18 years and above. This GEMCOVAC-19 vaccine is being seen as a gamechanger for the healthcare industry.

  3. health.economictimes.indiatimes.com › news › pharmaGennova Biopharmaceuticals mRNA COVID-19 ... - ET HealthWorld

    Jun 29, 2022 · Pune, India, June 29, 2022: Gennova Biopharmaceuticals announced that its mRNA vaccine – GEMCOVAC-19 - against COVID 19 received the emergency use authorisation ( EUA) from the office of the ...

  4. gennova.bio › productsProducts – Gennova Bio

    Till August 2016, Alteplase was the only approved treatment for acute ischemic stroke (AIS). In recent clinical trials conducted by Gennova, it has expanded the use of its Tenceteplase for the indication of AIS. Gennova’s Tenectase® is a pioneering product, where first time globally a 3rd generation thrombolytic was approved for stroke ...

  5. economictimes.indiatimes.com › industry › healthcareGennova Biopharma submits final vaccine trial data to ...

    Mar 11, 2022 · Gennova Biopharmaceuticals has presented data from human trials of its mRNA Covid-19 vaccine to India's drug regulatory authority for evaluation, people in the know said. Pune-based Gennova is developing the country's first indigenously developed mRNA vaccine for Covid-19. The subject expert committee under the drug regulator will take up its ...

  6. www.financialexpress.com › lifestyle › healthCovid-19: Gennova gets DCGI nod to start Phase II/IIII trials ...

    Aug 24, 2021 · Genova is a biotechnology focused company of the Pune-based pharma company, Emcure Pharmaceuticals. Gennova developed the vaccine in partnership with the support of the Department of ...

  7. www.linkedin.com › in › kelly-genova-413aa271Kelly Genova - Sr. Trainer, Learning and Consulting Services ...

    Sr. Trainer, Learning and Consulting Services · Experience: Signet Jewelers · Education: John Carroll University · Location: United States · 500+ connections on LinkedIn. View Kelly Genova’s ...

    • Signet Jewelers